Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D)

INTRODUCTION: Hyporesponsiveness to erythropoiesis-stimulating agents (ESAs) affects 10–15% of the chronic dialysis population. We explored baseline characteristics and predictors of ESA hyporesponsiveness in a global randomized cardiovascular outcomes study comparing an investigational hypoxia-indu...

Descripción completa

Detalles Bibliográficos
Autores principales: Macdougall, Iain C., Meadowcroft, Amy M., Blackorby, Allison, Cizman, Borut, Cobitz, Alexander R., Godoy, Sergio, Jha, Vivekanand, Johansen, Kirsten L., McMahon, Gearoid, Obrador, Gregorio T., Wong, Muh Geot, Singh, Ajay K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Patient-Oriented, Translational Research: Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210075/
https://www.ncbi.nlm.nih.gov/pubmed/36739866
http://dx.doi.org/10.1159/000528696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210075/
https://www.ncbi.nlm.nih.gov/pubmed/36739866
http://dx.doi.org/10.1159/000528696

Ejemplares similares